Mozersky J, Roberts SJ, Rumbaugh M, Chhatwal J, et al. Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants. J Alzheimers Dis 2022 Apr 8. pii: JAD220113. doi: 10.3233/JAD-220113.
PMID: 35404285